Singapore: In a bid to spur the country’s drug development and research, South Korea’s leading biopharmaceu...
Researchers at the Center for Nanoparticle Research, within the Institute for Basic Science (IBS) in collaboration with ...
Ina recent press conference held in Seoul, Korean biosimilar giant Celltrion said that it would actively seek out new dr...
Researchers at the Seoul National University Hospital have found out that coating stents with an erectile dysfunction dr...
India’s drug giant Sun Pharma has inked a long term manufacturing agreement with Korea’s Samsung Biologics f...
Orum Therapeutics based in Korea announced the completion of an $8 million Series A financing with InterVest, KB Investm...
Singapore: South Korean pharmaceutical companies are poised to release a series of important drugs in the second half of...
A recent study, affiliated with Ulsan National Institute of Science and Technology (UNIST), South Korea has proposed the...
NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd jointly announced that they have entered into a global lic...
Samsung announced that the GC70 Digital Radiography (DR) system received FDA 510(k) clearance for the U.S. market, under...
Singapore: In a bid to further provide a boost to South Korea's burgeoning biotech industry, the science ministry has es...
Singapore: The Korean Center for Disease Control and Prevention recently announced the opening of the country's first bi...
Singapore: San Diego Based Innovus Pharmaceuticals has announced that its partner J&H Co. LTD, a South Korean compan...
Singapore: South Korean pharmaceutical firm Mezzion Pharma has filed a suit against India's Dr Reddy's Laboratories Ltd ...
Singapore: With the South Korean pharma industry expanding, the size of the local pharma workforce grew by 27 percent co...
Singapore: Clinical trials for new Rituxan biosimilar has been initiated by a joint venture between Samsung Biologics an...
Singapore: Korea's National Institute of Food and Drug Safety Evaluation (NIFDS) has inked a deal with UK's National Ins...
Singapore: With a view to strengthen its biosimilars portfolio, Isreali drug giant Teva pharmaceuticals said that it may...